KAIST scientists have created a fast-acting, stable powder hemostat that stops bleeding in one second and could significantly ...
Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have developed an innovative spray-on, ...
The leading cause of death due to injuries in war is excessive bleeding. A KAIST research team, in which an Army Major participated, has tackled this issue head-on. By developing a next-generation ...
Marks Baxter’s entry into the attractive global hemostatic powder segment, broadening its portfolio offering to include a wider range of active and passive solutions Addressing intraoperative bleeding ...
In the study of over 200 patients, 90.1% of those who received TC-325 had their bleeding controlled within 30 days, as compared to 81.4% of those who received standard treatment, meeting criteria for ...
SEOUL, South Korea, May 29, 2025 /PRNewswire/ -- Nextbiomedical announced today that its novel hemostatic powder, Nexpowder™, has been published in GUT (Impact Factor: 23), one of the world's most ...
Marks first passive hemostat for Baxter in the U.S. market, broadening portfolio offering to include a full range of active and passive hemostatic products PERCLOT further enhances clinicians’ ability ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted clearance to Medtronic’s endoscopic hemostasis system, Nexpowder, intended to improve visibility ...
Marks Baxter’s entry into the attractive global hemostatic powder segment, broadening its portfolio offering to include a wider range of active and passive solutions Indications: PerClot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback